AEON Biopharma Inc AEON

US N/A
$0.29 β–² +14.81% (+$0.04)
⬆️ Above Yest. High 🎈 Low Float 🗓️ Earnings Next Week
Open $0.26
Prev Close $0.26
Day Range $0.25 – $0.34
52W Range $0.22 – $1.45
Market Cap $12.94M
Beta 0.60
EPS (TTM) $-4.16

πŸ“‹ Company Profile

IndustryN/A
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2021-10-08
Shares Out.37,155,500
Websiteaeonbiopharma.com/ β†—
Phone19492844555.0
Employees8
Net Income-$11.8M
Free Cash Flow-$12.0M
Total Assets$8.6M
Total Liabilities$25.4M
Equity-$16.8M
About AEON Biopharma Inc

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

AEON Biopharma Inc is a publicly traded company under the ticker symbol AEON on the NASDAQ NMS - GLOBAL MARKET, operating in the N/A industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

8 analysts (2026-07-01)

Strong Buy 2
Buy 5
Hold 1

πŸ“° Latest News for AEON

πŸ‘₯ Related Stocks